CXCR4 receptor antagonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10995091
APP PUB NO 20190062333A1
SERIAL NO

16167084

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The compounds of formula (I) are antagonists of the CXCR4 receptor

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PROXIMAGEN LLCPLYMOUTH MN 55441

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brown, Giles London, GB 9 87
Carley, Allison London, GB 8 34
Cole, Andrew Graham London, GB 5 20
Higginbottom, Michael Caldecote, GB 37 122
Oliver, Kathryn London, GB 12 34
Patient, Lee Linton, GB 24 97
Savory, Edward Daniel Cambourne, GB 13 48
Simpson, Iain Cambridge, GB 50 163
Stewart, Alison London, GB 9 35

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 4, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 4, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00